TNFAIP8 inhibits gastric cancer proliferation by mTOR-Akt-ULK1 and autophagy signal pathway

Background: The purpose of this article was to study the role of TNFAIP8 in gastric cancer. Methods: RT-PCR was used to detect the expression of TNFAIP8 mRNA and protein level in normal gastric mucosa cells and four gastric cancer (GC) cell lines. TNFAIP8 was silenced or overexpressed in two cell lines, CCK-8 cell viability was used, transwell experiment was used to detect cell invasion capability, and ow cytometry was used to detect cell apoptosis. TNFAIP was silenced or overexpressed in a cell line, and nude mice were inoculated to form transplanted tumors. HE staining and immunohistochemistry staining were used to detect the histopathological changes of tumors. Results: The mRNA and protein expression of TNFAIP8 was signicantly up-regulated in GC patients and cells. After silencing and overexpressing TNFAIP8, GC cells with high expression increased, apoptosis decreased, and cell invasion increased. Expression of mTOR-Akt-ULK1 signal pathway was inhibited and autophagy signal was activated. Conclusions: Our ndings indicate that TNFAIP8 inhibited GC cells by inhibiting mTOR-Akt-ULK1 signal pathway and activating autophagy signal.


Background
Gastric cancer (GC) is one of the most common and fatal malignant tumors in the world. It is di cult to treat, and it is easy to metastasize and spread. At the same time, its poor prognosis is related to lymph node and peritoneal metastasis of gastric cancer, which is the main cause of recurrence of GC [1].
According to statistics, the number of new gastric cancers and cancer deaths in the world in 2020 reached about 14.1 million and 8.2 million respectively [2]. Most of these cases occurred in developing countries. GC, as a common malignant tumor in digestive system, posed a serious threat to human health like liver cancer and colorectal cancer. Although its incidence rate has decreased in the past few years, its death rate was still the second highest among all kinds of malignant tumors [3]. Among the existing treatment methods, although surgical resection and adjuvant therapy have made great progress, and even some GC could be cured in the early stage, unfortunately most patients were found to be in the late stage, and the originally effective treatment methods have become ineffective or ineffective [4]. Therefore, it has become an urgent need for clinical workers and laboratory researchers to nd an effective tumor marker for early diagnosis and improvement of therapeutic effects.
A new candidate oncogene, tumor necrosis factor-a-induced protein 8 (TNF-AIP8) has gradually attracted the attention of scholars and extensive attention [5]. Members of this family include TNFAIP8, TNFAIP1 (TNF-AINDUCEDPLOTEIN 8-LIKE 1, TIPEL), TIPE2 and TIPE3F7L [6]. Although they have high homology, their biological behaviors were proved to be different in related experiments of Lord W. Among them, TNFAIP 8 is also called GG2-1, SCC-S2, MDC-3.13, which is the rst subtype found in this family [7]. The gene is located on chromosome 5q23.1 and is expressed in most malignant foot tumor tissues. Studies on these tumors have all suggested that signal transduction pathway affects many processes such as cell apoptosis, and therefore plays an important role in the formation and development of tumors [8]. In recent years, a series of functions of TNFAIP 8 in tumor formation have been continuously con rmed.
These results showed that TNFAIP 8 played an important role in the occurrence and development of tumors and was one of the important components in regulating cell apoptosis [9]. It was involved in the regulation of cell proliferation in different types of tumors, affecting invasion, migration, apoptosis and drug resistance. Previous studies have found that TNFAIP 8 expression could be detected in most malignant tumor tissues such as breast cancer, colon cancer, ovarian epithelial cell cancer, prostate cancer [6,10,11]. However, there are few reports on its research in GC and its mechanism is even less. The purpose of this article is to study its role in GC.
RT-qPCR detection of TNFAIP8 gene expression in several gastric cells GES-1, SGC-7901, NCI-N87, MKN-28, MGC-803 cells were cultured and collected to detect TNFAIP8 expression. Cell RNA was extracted according to Trizol reagent instructions and cDNA was synthesized according to cDNA reverse transcription kits instructions. RT-qPCR reaction was carried out on StepOnePlus real-time uorescence quantitative PCR system by two-step method. The reaction conditions were: pre-denaturation at 95°C for 95°C 1 min, denaturation at 95°C for 5 s, annealing and extension at 60°C for 60°C 30 S, with a total of 40 cycles.

Cell viability
Gastric cancer cells that were silent or overexpressed TNFAIP8 were inoculated into 96-well plates with 5,000 cells per well. One 96-well plate was taken out after 24, 48 and 72 h of conventional culture. 10 uL of CCK-8 solution (5 mg/m1) was added to each well and the culture was continued for 4 h. 150 mountains of DMSO solution was added to each well, and then were shake on a shaker at low speed for 10 min. At last, it was detected at 490 nm on the microplate reader.

Establishment of human gastric cancer model in nude mice
First, nude mice were adaptively fed for 1 week, and human gastric cancer MKN-28 cells which were silent in logarithmic growth phase and overexpressed TNFAIP8 gene after pancreatin digestion were collected, centrifuged at 800 rpm for 4 minutes, and the supernatant was discarded. It was made into a single cell suspension with a concentration of 2 × 10 7 cells/ml. In a sterile environment, 0.2 ml/nude mouse was inoculated under the armpit, and the nude mouse was put back into the cage to continue feeding and observe the state of the nude mouse. A week later, 24 nude mice showed subcutaneous nodules of about 5 mm, the model of human gastric cancer was established.
Cell transfection MKN-45 cells were seeded into 6-well plates 1 day before transfection. Transfection was prepared when adherent cells reached a fusion degree of 40% to 60%. The original medium was removed during transfection and washed with RPMI1640 medium (serum-free) 2 times. 4 μL of lipofectamine 2000 liposomes was added to 500 μL of serum-free RPMI1640 culture solution, while 10 μL of TNFAIP8 mimics storage solution was added to 500 μL of serum-free RPMI1640 medium, and allowed to stand at room temperature for 5 minutes, and then the two were mixed and allowed to stand at room temperature for 20 minutes. The mixed solution was added to the cells, and the nal concentration of mimics was 80 nmol/L. After 6 hours, the DMEM medium containing 10% fetal bovine serum was replaced, and the culture was continued to be expanded for subsequent experiments. RNA sequence of TNFAIP8 was: forward, 5′-T C C A T C G C C A C C A C C T T A-3′ and reverse, 5′-C T C T G C C T C

C T T C T T G T T T T-3′; GAPDH forward, 5′-G G C A A A T T C A A C G G C A C A G T C A-3′ and reverse, 5′-G T C T C G C T C C T G G A A G A T G G T G A T-3′.
Transwell experiment The small chamber was put into a culture plate, 300 μl of pre-heated serum-free culture medium was added into the upper chamber, and the upper chamber was left to stand for 15-30 min at room temperature to rehydrate the matrix glue; The remaining culture solution was sucked off, and the cells to be tested in each group were made into a cell suspension of 5×10 5 cells /ml using a serum-free medium containing bovine serum albumin (BSA). 100-200 μL of cell suspension was taken and added into Transwell upper chamber, and 500 μl of culture medium containing 20% FBS or chemokines was added into lower chamber; The cells at the bottom of the lower chamber were stained with 0. 5% crystal violet and the cells at the inner side of the upper chamber were removed with cotton swabs. Finally, cell morphology was observed under microscope and cell numbers was counted.

Ki-67 staining
Tumor tissues were xed with 4% formaldehyde and embedded in para n. All tissues were cut into 4 μm sections using a German thermoscience cryostat, and then tumor sections were incubated with primary Ki-67 antibody, sections were washed with PBS, secondary antibody were incubated according to the manufacturer's instructions.

Western blotting
The samples were minced and homogenized in ice-cold RIPA buffer containing 2 mM PMSF. Then samples were centrifugated at 12000 g for 15 min at 4°C. The total protein concentration was measured by the BCA assay kit. The proteins were subjected to SDS-PAGE electrophoresis, transferred to PVDF membranes, blocked with 5% skim dried milk for 2 h, and then probed with primary antibodies at 4 °C overnight. After that, it was incubated with HRP-conjugated secondary antibody for 2 h. The samples were visualized by an enhanced chemiluminescence (ECL) advanced kit and a gel imaging system (Tanon Science & Technology Co., Ltd., China).

Statistical analysis
All data were presented as mean ± SD. The statistical signi cance of differences between the means of each group was analyzed by one-way ANOVA followed by Tukey multiple comparison tests. For comparing two groups, Student's t test was used. A p value less than 0.05 was considered statistically signi cant.

TNFAIP8 gene expression and TNFAIP8 protein level in gastric mucosal cells and four types of gastric cancer cells
Compared with normal tissues, the expression of TNFAIP8 gene and TNFAIP8 protein level was higher in gastric cancer tissues ( Fig.1A and 1B), In addition, compared with normal gastric mucosa GES-1 cells, the expression of TNFAIP8 gene in four gastric cancer cells SGC-7901, NCI-N87, MKN-28, and MGC-803 was signi cantly increased (Fig.1C).
Overexpression of TNFAIP8 gene increased cell viability, reduced apoptotic rate and increased migration ability As shown in Figure 2A, in MKN-28 and MGC-803 cells, the silencing and over-expression of the TNFAIP8 gene was veri ed by PCR technology. Overexpression of TNFAIP8 gene obviously increased cell viability, reduced apoptotic rate and increased migration ability. In contrast, silent TNFAIP8 gene obviously genes obviously decreased cell viability, increased apoptotic rate and decreased migration ability (Fig. 2B, 2C, 2D).

Overexpression of TNFAIP8 gene increased tumor volume and tumor weight in transplanted tumor mice
Compared with normal cell transplanted tumor mice, over-expressing TNFAIP8 gene increased tumor volume and tumor quality in transplanted tumor mice, and silencing TNFAIP8 gene reduced tumor volume and tumor quality in transplanted tumor mice (Fig. 3A-3C). Ki67 immunohistochemical results showed that the number of positive cells with over-expressed TNFAIP8 gene was signi cantly reduced, and the number of positive cells with silenced TNFAIP8 gene was signi cantly reduced (Fig .3D).
Overexpression of TNFAIP8 gene activated autophagy and inhibited mTOR-Akt-ULK1 signaling pathway As shown in Fig. 4, over-expression of the TNFAIP8 gene signi cantly increased the ratio of LC3I/LC-3II and P-ULK1 level and decreased the levels of P62, P-PI3K, and P-mTOR. In contrast, silent of the TNFAIP8 gene signi cantly decreased the ratio of LC3I/LC-3II and P-ULK1 level and increased the levels of P62, P-PI3K, and P-mTOR.
Autophagy inhibitor and activator demonstrated the role of TNFAIP8 genes in regulating autophagy signals As shown in Fig. 5, over-expression of the TNFAIP8 gene signi cantly increased cell viability, decreased apoptotic rate and increased migration ability. However, autophagy inhibitor signi cantly reversed these changes, autophagy activator not only signi cantly reversed the above changes, but also reversed the changes of P-P3K, P-mTOR and p-ULK1 by overexpression of the TNFAIP8 gene (Fig.6).

Discussion
GC, as one of the common malignant tumors of the digestive system, poses a serious threat to human health as well as smart cancer and colorectal cancer [12,13]. In China, the current incidence of GC is 29.9 per 100,000 (male 41.3/100,000 vs. female 18.5/100,000), and the mortality rate is 22.3 per 100,000 (male 30.1/100,000). (VS. Women 14.6/100,000) [14,15]. The current treatment method for GC is comprehensive surgery (including adjuvant chemotherapy, molecular report drug treatment) [16]. Although surgical resection and adjuvant chemotherapy have made great progress in the treatment of GC, some GC can be cured at an early stage [17,18]. Unfortunately, most patients are already in an incurable stage when they are discovered. Originally effective treatments have become ineffective or ineffective, and the overall prognosis is poor. The detection of EGF, cycinE, p27, CD44v6, MMP-1, TIMP-1, HER-2, HER-3, and VEGF may have important signi cance for the individualized treatment of GC patients [19,20]. However, the mechanism of gastric cancer has not been fully clari ed so far, and there is no effective indicator for early diagnosis, early treatment, improved prognosis, and prolonged patient survival. Therefore, whether or not to nd an effective tumor marker for early diagnosis and improve the treatment effect has become an urgent need for clinicians and laboratory researchers.
Recently, a new candidate oncogene, tumor necrosis factor-a-inducing protein 8 (Tumorcrosis factor-ainduce protein 8, TNFAJP8), has gradually come into the sight of scholars and has attracted widespread attention [21,22]. In recent years, a series of roles of TNFAIP8 in tumor formation have been continuously con rmed. These results showed that TNFAIP8 played a vital role in the development of tumors. It was involved in the regulation of cell proliferation in different tumor types, and tumor invasion, migration, death, and drug resistance. Xing et al. measured the expression of TNFAIP8 in non-small cell lung cancer tissues and adjacent normal lung tissues [23]. Miao et al. analyzed the expression pattern of TNFAIP8 in 92 colon cancer tissues by immunohistochemistry, and found that TNFAIP8 was overexpressed in 45 patients (48.9%). Although TNFAIP8 plays a vital role in the genesis and development of tumors, the expression of TNFAIP8 in gastric cancer and its role in regulating the growth, invasion and migration of gastric cancer cells have not been determined. In our study, PCR results found that compared with normal tissues, the TNFAIP8 gene was signi cantly increased in gastric cancer tissues. In addition, compared with normal gastric mucosa tissue, TNFAIP8 genes were signi cantly increased in the four gastric cancer tissues. This result indicates that TNFAIP8 gene is involved in the pathological process of gastric cancer.
At present, there are few studies on the role of TNFAIP8 in gastric cancer, and it is di cult to determine whether down-regulation of TNFAIP8 will affect the biological characteristics of gastric cancer cells. In the rst experiment, we have con rmed that TNFAIP8 was expressed in gastric cancer tissues and tissues, and its expression is higher than that of paracancerous tissue and normal gastric mucosal cells, suggesting that TNFAIP8 was closely related to the occurrence and development of gastric cancer.
At present, a type of cell death that does not depend on the apoptotic pathway-cell autophagy has become a research hotspot. On the one hand, autophagy can play an anti-tumor and anti-aging effect, but on the other hand, the autophagy process provided cells with nutrients to help them survive the harsh environment and also play a role in promoting the development of tumors [24]. It is a "double-edged sword" in the process of tumorigenesis and development. Hypoxia, ischemia, and radiation therapy can cause tumor cell autophagy to increase, tumor tissue lacks blood supply, and metastasis is prone to place tumor cells in a metabolic stress state [25]. In this study, over-expression of the TNFAIP8 signi cantly increased cell viability, decreased apoptotic rate and increased migration ability. However, autophagy inhibitor and activator signi cantly reversed these changes. The above phenomenon is very interesting, suggesting that the TNFAIP8 gene may have effect on tumor cells by activating autophagy signals and regulated the pathophysiology of gastric cancer.
Akt is a key molecule downstream of PI3K. It binds to PI3K through its N-terminal PH domain. At the same time, it can regulate the proliferation and survival of many types of cells [26]. Akt acts as a key regulator of multiple cell proliferation, differentiation and survival. mTOR is an important substrate of ATK, as a large protein with a C-terminal serine/threonine PI3K-related kinase domain. The mTOR signal pathway, as an important cell signal transduction pathway, is involved in physiological activities such as cell growth, survival, and autophagy. Studies have also shown that abnormal mTOR signals have profound effects on cell homeostasis, and may even lead to the development of pathological conditions, such as gastric cancer [27]. Tian et al used immunohistochemistry to detect the expression of AKT in tumor tissues and adjacent tissues of 128 patients with gastric cancer, and found that the expression level of AKT in tumor tissues was signi cantly higher than that in adjacent tissues and was related to the T stage [28]. The expression of phosphorylated AKT (phospho-AKT, p-AKT) was detected in tissue samples from 231 patients with gastric cancer. It was found that p-AKT was expressed in 119 samples (53%). Statistical analysis showed that p-AKT Poor patient prognosis. Li et al. detected the expression of mTOR in 33 patients with GC and 30 healthy controls by immunohistochemistry, and found that the expression rate of mTOR in patients with GC was 51.5%. There is almost no mTOR expression, suggesting that mTOR activation occurs during the occurrence and development of GC [29]. In addition, the study also found that mTOR expression is associated with late tumor stage, poor differentiation, and lymph node metastasis. ULK1 (Unc-51. Like. Autophage. Akinting. Kinase) complex initiates the formation of autosome. ULK1 could be regulated by mTORC1 and MAPK-related kinases. mTORC1 integrated growth factors, regulated oxygen content, amino acids and energy, and promote the synthesis of proteins related to cell growth metabolism [30]. When mTORC1 is activated, it reduced the activity of ULK1 kinase by phosphorylating ULK1 and ATG13. In this study, we investigated the relationship between the TNFAIP8 and the mTOR-Akt-ULK1signaling pathway and its role in gastric cancer. Our results showed that over-expressing TNFAIP8 signi cantly reduced p-Akt and p-mTOR levels and increased p-ULK1 level. In contrast, silenced TNFAIP8 signi cantly increased p-Akt and p-mTOR levels, and signi cantly reduced p-ULK1 level. Even more interesting was that when autophagy activators are added, these changes are signi cantly reversed. The above results showed that the TNFAIP8 inhibited the mTOR-Akt-ULK1 and involved in the physiological and pathological processes of gastric cancer.

Conclusion
In summary, this study found that the TNFAIP8 was highly expressed in gastric cancer tissues, and found that TNFAIP8 signi cantly inhibited the mTOR-Akt-ULK1 signaling pathway and activated autophagy signal. The above mechanisms may be involved in the physiological and pathological processes of gastric cancer and also provided a new target for treatment of gastric cancer.
Abbreviations GC: Gastric cancer; TNF-AIP 8: Tumor necrosis factor-a-induced protein 8; ECL: Enhanced chemiluminescence; TIPE1: TNF-induceprotein8-lick1 Declarations Ethics approval and consent to participate All the experimental procedures were approved and executed in accordance with the Institutional Animal Care and Use Committee of Shandong Provincial Hospital A liated to Shandong First Medical University.

Consent for publication
Not applicable.

Availability of data and material
The data used to support the ndings of this study are included in the article.

Competing Interest
There are no con icts of interest to declare.

Funding
Not applicable.